STARPHARMA (SLP7013-017)

A phase 3, double-blind, multicentre, randomised, placebo-controlled study to determine the efficacy and safety of SPL7013 Gel (VivaGel®) to prevent the recurrence of bacterial vaginosis

BV (bacterial vaginosis) is the most common vaginal infection worldwide. It is often referred to as an imbalance of the natural vaginal pH.

The Harmony Program is investigating a potential medication to stop BV from coming back after an episode.

Your body needs harmony.

You may be eligible to participate in the Harmony Program if you:

    • are a woman who is between 18 and 45 years of age

    • have had at least two episodes of BV in the past year, and have another recurrence

  • If you are interested in taking part in the Harmony Program, or if you would like more information, pleasecontact the Harmony Program Study Team.

You can find more information here

 

Sign Up